These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38522883)
1. Endoscopic resection for residual oesophageal neoplasia after definitive chemoradiotherapy. Honing J; Koch AD; Siersema PD; Spaander M Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101885. PubMed ID: 38522883 [TBL] [Abstract][Full Text] [Related]
2. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer. Makazu M; Kato K; Takisawa H; Yoshinaga S; Oda I; Saito Y; Mayahara H; Ito Y; Itami J; Hamaguchi T; Yamada Y; Shimada Y Dis Esophagus; 2014 Jan; 27(1):42-9. PubMed ID: 23442160 [TBL] [Abstract][Full Text] [Related]
3. Salvage endoscopic resection for cT1N0M0 local recurrence after chemoradiotherapy for esophageal squamous cell carcinoma: endoscopic submucosal dissection versus endoscopic mucosal resection. Nakajo K; Yoda Y; Yamashita H; Takashima K; Murano T; Kadota T; Shinmura K; Ikematsu H; Akimoto T; Yano T Jpn J Clin Oncol; 2022 Sep; 52(9):982-991. PubMed ID: 35675653 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of endoscopic submucosal dissection for early oesophageal squamous cell neoplasia at a Western centre. Lorenzo D; Barret M; Leblanc S; Terris B; Beuvon F; Coriat R; Chaussade S; Prat F United European Gastroenterol J; 2019 Oct; 7(8):1084-1092. PubMed ID: 31662865 [TBL] [Abstract][Full Text] [Related]
5. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Takeuchi M; Kobayashi M; Hashimoto S; Mizuno K; Kawaguchi G; Sasamoto R; Aoyama H; Aoyagi Y Scand J Gastroenterol; 2013 Sep; 48(9):1095-101. PubMed ID: 23906093 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion. Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review. Tsou YK; Lee CH; Le PH; Chen BH Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674 [TBL] [Abstract][Full Text] [Related]
8. Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER? Hombu T; Yano T; Hatogai K; Kojima T; Kadota T; Onozawa M; Yoda Y; Hori K; Oono Y; Ikematsu H; Fujii S Dig Endosc; 2018 May; 30(3):338-346. PubMed ID: 29106753 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of salvage endoscopic submucosal dissection for local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Kimura H; Yoshida M; Yabuuchi Y; Kakushima N; Yamamoto Y; Kawata N; Takizawa K; Kishida Y; Imai K; Ito S; Hotta K; Ishiwatari H; Matsubayashi H; Ono H Jpn J Clin Oncol; 2021 Jul; 51(7):1036-1043. PubMed ID: 33758950 [TBL] [Abstract][Full Text] [Related]
10. Minimally invasive hybrid surgery: A salvage tumor enucleation for local recurrence of thoracic esophageal carcinoma after definitive chemoradiotherapy. Kanamori J; Abe S; Kurita D; Ishiyama K; Hirano Y; Oguma J; Oda I; Saito Y; Daiko H Asian J Endosc Surg; 2021 Jan; 14(1):77-80. PubMed ID: 32633076 [TBL] [Abstract][Full Text] [Related]
11. Review of early endoscopic findings in patients with local recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Yamamoto Y; Kadota T; Yoda Y; Hori K; Hatogai K; Kojima T; Fujii S; Akimoto T; Yano T Esophagus; 2020 Oct; 17(4):433-439. PubMed ID: 32232702 [TBL] [Abstract][Full Text] [Related]
12. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study. Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830 [TBL] [Abstract][Full Text] [Related]
13. Salvage Endoscopic Submucosal Dissection for Local Recurrence of Superficial Esophageal Squamous Cell Cancer after Photodynamic Therapy. Kanamori A; Goda K; Nakamura T; Yamagishi H; Ohwada A; Abe K; Suzuki T; Kondo M; Tanaka T; Yamamiya A; Takimoto Y; Hoshi K; Arisaka T; Sugaya T; Tominaga K; Majima Y; Iijima M; Irisawa A Intern Med; 2022 Jul; 61(14):2149-2153. PubMed ID: 34980795 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy. Ego M; Abe S; Nakatani Y; Nonaka S; Suzuki H; Yoshinaga S; Oda I; Kato K; Honma Y; Itami J; Daiko H; Saito Y; Boku N Surg Endosc; 2021 Apr; 35(4):1766-1776. PubMed ID: 32356109 [TBL] [Abstract][Full Text] [Related]
15. Salvage endoscopic resection after definitive chemoradiotherapy for esophageal cancer: a Western experience. Al-Kaabi A; Schoon EJ; Deprez PH; Seewald S; Groth S; Giovannini M; Braden B; Berr F; Lemmers A; Hoare J; Bhandari P; van der Post RS; Verhoeven RHA; Siersema PD Gastrointest Endosc; 2021 Apr; 93(4):888-898.e1. PubMed ID: 32763242 [TBL] [Abstract][Full Text] [Related]
16. Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer. Hatogai K; Yano T; Kojima T; Onozawa M; Fujii S; Daiko H; Yoda Y; Hombu T; Doi T; Kaneko K; Ohtsu A Radiat Oncol; 2016 Feb; 11():31. PubMed ID: 26922374 [TBL] [Abstract][Full Text] [Related]
17. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma. Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070 [TBL] [Abstract][Full Text] [Related]
18. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone. Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Definitive Chemoradiotherapy Versus Radical Esophagectomy in Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma. Haneda R; Booka E; Ishii K; Kikuchi H; Hiramatsu Y; Kamiya K; Ogawa H; Yasui H; Takeuchi H; Tsubosa Y World J Surg; 2021 Jun; 45(6):1835-1844. PubMed ID: 33620541 [TBL] [Abstract][Full Text] [Related]
20. Does cervical lymph node recurrence after oesophagectomy or definitive chemoradiotherapy for thoracic oesophageal squamous cell carcinoma benefit from salvage treatment? Yuan X; Lv J; Dong H; Wang J Interact Cardiovasc Thorac Surg; 2017 May; 24(5):792-795. PubMed ID: 28453803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]